Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study

• Egile Nagusiak: Elisa Molinelli (Egilea), Anna Campanati (Egilea), Valerio Brisigotti (Egilea), Claudia Sapigni (Egilea), Matteo Paolinelli (Egilea), Annamaria Offidani (Egilea)
• Formatua: Liburua
• Argitaratua: Adis, Springer Healthcare, 2020-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Introduction Alopecia areata (AA) is a chronic inflammatory non-scarring type of hair loss. Current therapies for alopecia areata are rather limited and mainly involve the use of topical, intra-lesional or systemic steroids and topical immunotherapy, with variable benefit. Recent studies ha...